Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,043 mentions
- robotic manipulationmarket824 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology491 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology371 mentions
- agentic AItechnology353 mentions
- vision-language-action modeltechnology350 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Vision-Language Modeltechnology318 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology175 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology169 mentions
- IBMorganization163 mentions
Entity
Evommune, Inc.
organization1 mentionslast seen Nov 4, 2026
Clinical-stage biotechnology company developing therapies for chronic inflammatory diseases.
Relationships 14
- Evommune, Inc.employsJeegar Patel95% confidence1 source
- Evommune, Inc.employsGreg Moss95% confidence1 source
- Evommune, Inc.employsLuis Peña95% confidence1 source
- Evommune, Inc.acquiresEVO57092% confidence1 source
- Evommune, Inc.funded byEvommune Series Private Placement November 202692% confidence1 source
- Evommune, Inc.commercializesEVO57090% confidence1 source
- Evommune, Inc.developsEVO57090% confidence1 source
- Evommune, Inc.partners withHinova Pharmaceuticals Inc.88% confidence1 source
- Evommune, Inc.developsEVO30185% confidence1 source
- Adage Capital Partners LPinvests inEvommune, Inc.85% confidence1 source
- Balyasny Asset Managementinvests inEvommune, Inc.85% confidence1 source
- OrbiMedinvests inEvommune, Inc.85% confidence1 source
- Evommune, Inc.developsEVO64685% confidence1 source
- Evommune, Inc.developsEVO75685% confidence1 source
Relationship
OrbiMedinvests inEvommune, Inc.
85% confidence1 supporting mentionsfrom Nov 4, 2026
Either name opens that entity’s relationships.
Sources 1